Publication | Open Access
Use of Multimodal Imaging and Clinical Biomarkers in Presymptomatic Carriers of <i>C9orf72</i> Repeat Expansion
70
Citations
30
References
2020
Year
The results suggest that [18F]FDG PET can identify glucose metabolic changes in preSxC9 at an individual level, preceding significantly elevated neurofilament levels and onset of symptoms.
| Year | Citations | |
|---|---|---|
Page 1
Page 1